MY133181A - Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines - Google Patents
Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistaminesInfo
- Publication number
- MY133181A MY133181A MYPI99003509A MYPI9903509A MY133181A MY 133181 A MY133181 A MY 133181A MY PI99003509 A MYPI99003509 A MY PI99003509A MY PI9903509 A MYPI9903509 A MY PI9903509A MY 133181 A MY133181 A MY 133181A
- Authority
- MY
- Malaysia
- Prior art keywords
- methods
- compositions
- otitis media
- antihistamines
- related disorders
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 206010033078 Otitis media Diseases 0.000 title abstract 2
- 201000009890 sinusitis Diseases 0.000 title abstract 2
- 229940125715 antihistaminic agent Drugs 0.000 title 1
- 239000000739 antihistaminic agent Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003246 corticosteroid Substances 0.000 abstract 3
- 229960001334 corticosteroids Drugs 0.000 abstract 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 abstract 1
- 229960001664 mometasone Drugs 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
THE PRESENT INVENTIN DISCLOSED ANTIBIOTIC-EXCLUDED COMPOSITIONS AND METHODS TO TREAT NON-INFECTIVE SINUSITIS AND OTITIS MEDIA. THE COMPOSITIONS COMPRISE A THERAPEUTICALLY EFFECTIVE AMOUNT OF A CORTICOSTEROID, AND THE METHODS COMPRISE ADMINISTERING A PHARMACEUTICAL COMPOSITION COMPRISING A THERAPEUTICALLY EFFECTIVE AMOUNT OF A CORTICOSTEROID. PREFERRED CORTICOSTEROIDS ARE MOMETASONE FURATE AND MONE TASON FURATE MONOHYDRATE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15084798A | 1998-09-10 | 1998-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY133181A true MY133181A (en) | 2007-10-31 |
Family
ID=22536243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI99003509A MY133181A (en) | 1998-09-10 | 1999-08-16 | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR022084A1 (en) |
| AU (1) | AU6018999A (en) |
| CO (1) | CO5160268A1 (en) |
| MY (1) | MY133181A (en) |
| PA (1) | PA8481701A1 (en) |
| PE (1) | PE20001051A1 (en) |
| TW (1) | TW589185B (en) |
| WO (1) | WO2000015234A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| CA2576589C (en) * | 2004-08-13 | 2013-11-12 | Schering-Plough Ltd. | Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061729A (en) * | 1988-06-08 | 1991-10-29 | Biogal Gyogyszergyar | Pharmaceutical composition and process for preparing the same |
| DK0548114T5 (en) * | 1990-09-10 | 1995-01-30 | Schering Corp | Mometasone furoate monohydrate, process for its preparation and pharmaceutical preparations containing this |
| PE44995A1 (en) * | 1994-01-27 | 1995-12-18 | Schering Corp | MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT |
| FR2756739B1 (en) * | 1996-12-05 | 2000-04-28 | Astra Ab | NEW BUDESONIDE FORMULATION |
-
1999
- 1999-08-16 MY MYPI99003509A patent/MY133181A/en unknown
- 1999-09-09 TW TW088115545A patent/TW589185B/en not_active IP Right Cessation
- 1999-09-09 WO PCT/US1999/018840 patent/WO2000015234A1/en not_active Ceased
- 1999-09-09 CO CO99057225A patent/CO5160268A1/en unknown
- 1999-09-09 PE PE1999000910A patent/PE20001051A1/en not_active Application Discontinuation
- 1999-09-09 AR ARP990104541A patent/AR022084A1/en unknown
- 1999-09-09 AU AU60189/99A patent/AU6018999A/en not_active Abandoned
- 1999-09-09 PA PA19998481701A patent/PA8481701A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000015234A1 (en) | 2000-03-23 |
| PA8481701A1 (en) | 2000-09-29 |
| AR022084A1 (en) | 2002-09-04 |
| CO5160268A1 (en) | 2002-05-30 |
| AU6018999A (en) | 2000-04-03 |
| PE20001051A1 (en) | 2000-10-17 |
| TW589185B (en) | 2004-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA70919C2 (en) | Composition for treating and preventing arterial thrombosis based on selective inhibitors of factor xa alone or in combination with compounds possessing anti-platelet aggregation activity | |
| AP1637A (en) | Celecoxib compositions. | |
| GB2303850B (en) | Metalloproteinase inhibitors | |
| WO2003068171A3 (en) | Method and composition for treatment of inflammation and aids-associated neurological disorders | |
| YU37602A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
| NZ592039A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
| MY127082A (en) | Synergistic methods and compositions for treating cancer | |
| NO20013859D0 (en) | Cyclooxygenase-2 inhibitor preparations that rapidly provide therapeutic effect | |
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| AU2275397A (en) | Troponin subunits and fragments useful as angiogenesis inhibitors | |
| WO2001030802A3 (en) | Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies | |
| EP1348466A3 (en) | Method for treating pain with adenosine-tetraphosphates | |
| MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
| WO2001068125A3 (en) | Methods and compositions for the treatment and prevention of erectile dysfunction | |
| CA2283399A1 (en) | Pyridazinones as inhibitors of cyclooxygenase-2 | |
| NZ271363A (en) | Use of antiglucocorticoid steroids to treat anxiety disorders | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| MY117918A (en) | Use of an h+, k+- atpase inhibitor in the treatment of nasal polyps | |
| EP1032556A4 (en) | Pharmaceutically active compounds and methods of use | |
| MX9403088A (en) | Indole derivatives. | |
| AU5170400A (en) | Topical application of muscarinic and opioid agents for treatment of tinnitus | |
| NO943288L (en) | Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease | |
| MD1521G2 (en) | Methods of thrombus forming inhibition methods of tretment of thrombotic states, pharmaceutical compositions and kit for treatment of thrombotic states | |
| RU94041028A (en) | Application of melatonin derivatives for treating desynchronization disorders, pharmaceutical composition | |
| MY130725A (en) | Composition and method for treating allergic diseases |